Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. [electronic resource]
Producer: 20010628Description: 390-400 p. digitalISSN:- 1360-2276
- Adult
- Angola
- Central Nervous System Protozoal Infections -- chemically induced
- Drug Administration Schedule
- Female
- Humans
- Male
- Melarsoprol -- administration & dosage
- Middle Aged
- Predictive Value of Tests
- Risk Factors
- Syndrome
- Time Factors
- Treatment Outcome
- Trypanocidal Agents -- administration & dosage
- Trypanosomiasis, African -- complications
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.